336 Risks of COVID-19 infection and mortality for patients on biologics

por Pahalyants, V., Murphy, W., Klebanov, N., Theodosakis, N., Klevens, M., Lilly, E., Asgari, M., Semenov, Y.
Publicado 2021

028 Use of systemic immunosuppressive treatment is not related to COVID-19 infection in a retrospective review of patients in Massachusetts

por Murphy, W., Klebanov, N., Pahalyants, V., Theodosakis, N., Patel, K., Klevens, M., Lilly, E., Semenov, Y.
Publicado 2021